Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Blood Test
1.2.3 Urine Test
1.2.4 Saliva Test
1.3 Market by Application
1.3.1 Global Liquid Biopsy For Cancer Diagnostics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liquid Biopsy For Cancer Diagnostics Market Perspective (2018-2033)
2.2 Liquid Biopsy For Cancer Diagnostics Growth Trends by Region
2.2.1 Global Liquid Biopsy For Cancer Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Liquid Biopsy For Cancer Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Liquid Biopsy For Cancer Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Liquid Biopsy For Cancer Diagnostics Market Dynamics
2.3.1 Liquid Biopsy For Cancer Diagnostics Industry Trends
2.3.2 Liquid Biopsy For Cancer Diagnostics Market Drivers
2.3.3 Liquid Biopsy For Cancer Diagnostics Market Challenges
2.3.4 Liquid Biopsy For Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liquid Biopsy For Cancer Diagnostics Players by Revenue
3.1.1 Global Top Liquid Biopsy For Cancer Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Liquid Biopsy For Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liquid Biopsy For Cancer Diagnostics Revenue
3.4 Global Liquid Biopsy For Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Liquid Biopsy For Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liquid Biopsy For Cancer Diagnostics Revenue in 2022
3.5 Liquid Biopsy For Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Liquid Biopsy For Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Liquid Biopsy For Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liquid Biopsy For Cancer Diagnostics Breakdown Data by Type
4.1 Global Liquid Biopsy For Cancer Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Liquid Biopsy For Cancer Diagnostics Forecasted Market Size by Type (2024-2033)
5 Liquid Biopsy For Cancer Diagnostics Breakdown Data by Application
5.1 Global Liquid Biopsy For Cancer Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Liquid Biopsy For Cancer Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Liquid Biopsy For Cancer Diagnostics Market Size (2018-2033)
6.2 North America Liquid Biopsy For Cancer Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2018-2023)
6.4 North America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liquid Biopsy For Cancer Diagnostics Market Size (2018-2033)
7.2 Europe Liquid Biopsy For Cancer Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Liquid Biopsy For Cancer Diagnostics Market Size by Country (2018-2023)
7.4 Europe Liquid Biopsy For Cancer Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liquid Biopsy For Cancer Diagnostics Market Size (2018-2033)
9.2 Latin America Liquid Biopsy For Cancer Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffman La Roche Ltd.
11.1.1 F. Hoffman La Roche Ltd. Company Detail
11.1.2 F. Hoffman La Roche Ltd. Business Overview
11.1.3 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Introduction
11.1.4 F. Hoffman La Roche Ltd. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.1.5 F. Hoffman La Roche Ltd. Recent Development
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Detail
11.2.2 Thermo Fisher Scientific Inc. Business Overview
11.2.3 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.2.5 Thermo Fisher Scientific Inc. Recent Development
11.3 Agilent Technologies Inc.
11.3.1 Agilent Technologies Inc. Company Detail
11.3.2 Agilent Technologies Inc. Business Overview
11.3.3 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Introduction
11.3.4 Agilent Technologies Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.3.5 Agilent Technologies Inc. Recent Development
11.4 Illumina Inc.
11.4.1 Illumina Inc. Company Detail
11.4.2 Illumina Inc. Business Overview
11.4.3 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Introduction
11.4.4 Illumina Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.4.5 Illumina Inc. Recent Development
11.5 The Menarini Group
11.5.1 The Menarini Group Company Detail
11.5.2 The Menarini Group Business Overview
11.5.3 The Menarini Group Liquid Biopsy For Cancer Diagnostics Introduction
11.5.4 The Menarini Group Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.5.5 The Menarini Group Recent Development
11.6 Bio-Rad Laboratories Inc.
11.6.1 Bio-Rad Laboratories Inc. Company Detail
11.6.2 Bio-Rad Laboratories Inc. Business Overview
11.6.3 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Introduction
11.6.4 Bio-Rad Laboratories Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.6.5 Bio-Rad Laboratories Inc. Recent Development
11.7 QIAGEN Inc.
11.7.1 QIAGEN Inc. Company Detail
11.7.2 QIAGEN Inc. Business Overview
11.7.3 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Introduction
11.7.4 QIAGEN Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.7.5 QIAGEN Inc. Recent Development
11.8 Exact Sciences Corporation
11.8.1 Exact Sciences Corporation Company Detail
11.8.2 Exact Sciences Corporation Business Overview
11.8.3 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Introduction
11.8.4 Exact Sciences Corporation Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.8.5 Exact Sciences Corporation Recent Development
11.9 Bio-Techne Corporation
11.9.1 Bio-Techne Corporation Company Detail
11.9.2 Bio-Techne Corporation Business Overview
11.9.3 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Introduction
11.9.4 Bio-Techne Corporation Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.9.5 Bio-Techne Corporation Recent Development
11.10 ArcherDX Inc.
11.10.1 ArcherDX Inc. Company Detail
11.10.2 ArcherDX Inc. Business Overview
11.10.3 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Introduction
11.10.4 ArcherDX Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.10.5 ArcherDX Inc. Recent Development
11.11 Neogenomics Laboratories Inc.
11.11.1 Neogenomics Laboratories Inc. Company Detail
11.11.2 Neogenomics Laboratories Inc. Business Overview
11.11.3 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Introduction
11.11.4 Neogenomics Laboratories Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.11.5 Neogenomics Laboratories Inc. Recent Development
11.12 Guardant Health Inc.
11.12.1 Guardant Health Inc. Company Detail
11.12.2 Guardant Health Inc. Business Overview
11.12.3 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Introduction
11.12.4 Guardant Health Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.12.5 Guardant Health Inc. Recent Development
11.13 Myriad Genetics Inc.
11.13.1 Myriad Genetics Inc. Company Detail
11.13.2 Myriad Genetics Inc. Business Overview
11.13.3 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Introduction
11.13.4 Myriad Genetics Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.13.5 Myriad Genetics Inc. Recent Development
11.14 Foundation Medicine Inc.
11.14.1 Foundation Medicine Inc. Company Detail
11.14.2 Foundation Medicine Inc. Business Overview
11.14.3 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Introduction
11.14.4 Foundation Medicine Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.14.5 Foundation Medicine Inc. Recent Development
11.15 Amoy Diagnostics Co. Ltd.
11.15.1 Amoy Diagnostics Co. Ltd. Company Detail
11.15.2 Amoy Diagnostics Co. Ltd. Business Overview
11.15.3 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Introduction
11.15.4 Amoy Diagnostics Co. Ltd. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.15.5 Amoy Diagnostics Co. Ltd. Recent Development
11.16 Biocartis Group NV
11.16.1 Biocartis Group NV Company Detail
11.16.2 Biocartis Group NV Business Overview
11.16.3 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Introduction
11.16.4 Biocartis Group NV Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
11.16.5 Biocartis Group NV Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Blood Test
Table 3. Key Players of Urine Test
Table 4. Key Players of Saliva Test
Table 5. Global Liquid Biopsy For Cancer Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Liquid Biopsy For Cancer Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Liquid Biopsy For Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Liquid Biopsy For Cancer Diagnostics Market Share by Region (2018-2023)
Table 9. Global Liquid Biopsy For Cancer Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Liquid Biopsy For Cancer Diagnostics Market Share by Region (2024-2033)
Table 11. Liquid Biopsy For Cancer Diagnostics Market Trends
Table 12. Liquid Biopsy For Cancer Diagnostics Market Drivers
Table 13. Liquid Biopsy For Cancer Diagnostics Market Challenges
Table 14. Liquid Biopsy For Cancer Diagnostics Market Restraints
Table 15. Global Liquid Biopsy For Cancer Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Liquid Biopsy For Cancer Diagnostics Market Share by Players (2018-2023)
Table 17. Global Top Liquid Biopsy For Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Biopsy For Cancer Diagnostics as of 2022)
Table 18. Ranking of Global Top Liquid Biopsy For Cancer Diagnostics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Liquid Biopsy For Cancer Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Liquid Biopsy For Cancer Diagnostics Product Solution and Service
Table 22. Date of Enter into Liquid Biopsy For Cancer Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Liquid Biopsy For Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Type (2018-2023)
Table 26. Global Liquid Biopsy For Cancer Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Type (2024-2033)
Table 28. Global Liquid Biopsy For Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Application (2018-2023)
Table 30. Global Liquid Biopsy For Cancer Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Application (2024-2033)
Table 32. North America Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Liquid Biopsy For Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Liquid Biopsy For Cancer Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 47. F. Hoffman La Roche Ltd. Company Detail
Table 48. F. Hoffman La Roche Ltd. Business Overview
Table 49. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product
Table 50. F. Hoffman La Roche Ltd. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 51. F. Hoffman La Roche Ltd. Recent Development
Table 52. Thermo Fisher Scientific Inc. Company Detail
Table 53. Thermo Fisher Scientific Inc. Business Overview
Table 54. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product
Table 55. Thermo Fisher Scientific Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 56. Thermo Fisher Scientific Inc. Recent Development
Table 57. Agilent Technologies Inc. Company Detail
Table 58. Agilent Technologies Inc. Business Overview
Table 59. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product
Table 60. Agilent Technologies Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 61. Agilent Technologies Inc. Recent Development
Table 62. Illumina Inc. Company Detail
Table 63. Illumina Inc. Business Overview
Table 64. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product
Table 65. Illumina Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 66. Illumina Inc. Recent Development
Table 67. The Menarini Group Company Detail
Table 68. The Menarini Group Business Overview
Table 69. The Menarini Group Liquid Biopsy For Cancer Diagnostics Product
Table 70. The Menarini Group Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 71. The Menarini Group Recent Development
Table 72. Bio-Rad Laboratories Inc. Company Detail
Table 73. Bio-Rad Laboratories Inc. Business Overview
Table 74. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product
Table 75. Bio-Rad Laboratories Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 76. Bio-Rad Laboratories Inc. Recent Development
Table 77. QIAGEN Inc. Company Detail
Table 78. QIAGEN Inc. Business Overview
Table 79. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product
Table 80. QIAGEN Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 81. QIAGEN Inc. Recent Development
Table 82. Exact Sciences Corporation Company Detail
Table 83. Exact Sciences Corporation Business Overview
Table 84. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product
Table 85. Exact Sciences Corporation Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 86. Exact Sciences Corporation Recent Development
Table 87. Bio-Techne Corporation Company Detail
Table 88. Bio-Techne Corporation Business Overview
Table 89. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product
Table 90. Bio-Techne Corporation Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 91. Bio-Techne Corporation Recent Development
Table 92. ArcherDX Inc. Company Detail
Table 93. ArcherDX Inc. Business Overview
Table 94. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product
Table 95. ArcherDX Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 96. ArcherDX Inc. Recent Development
Table 97. Neogenomics Laboratories Inc. Company Detail
Table 98. Neogenomics Laboratories Inc. Business Overview
Table 99. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product
Table 100. Neogenomics Laboratories Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 101. Neogenomics Laboratories Inc. Recent Development
Table 102. Guardant Health Inc. Company Detail
Table 103. Guardant Health Inc. Business Overview
Table 104. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product
Table 105. Guardant Health Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 106. Guardant Health Inc. Recent Development
Table 107. Myriad Genetics Inc. Company Detail
Table 108. Myriad Genetics Inc. Business Overview
Table 109. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product
Table 110. Myriad Genetics Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 111. Myriad Genetics Inc. Recent Development
Table 112. Foundation Medicine Inc. Company Detail
Table 113. Foundation Medicine Inc. Business Overview
Table 114. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product
Table 115. Foundation Medicine Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 116. Foundation Medicine Inc. Recent Development
Table 117. Amoy Diagnostics Co. Ltd. Company Detail
Table 118. Amoy Diagnostics Co. Ltd. Business Overview
Table 119. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product
Table 120. Amoy Diagnostics Co. Ltd. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 121. Amoy Diagnostics Co. Ltd. Recent Development
Table 122. Biocartis Group NV Company Detail
Table 123. Biocartis Group NV Business Overview
Table 124. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product
Table 125. Biocartis Group NV Revenue in Liquid Biopsy For Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 126. Biocartis Group NV Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liquid Biopsy For Cancer Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Liquid Biopsy For Cancer Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Blood Test Features
Figure 4. Urine Test Features
Figure 5. Saliva Test Features
Figure 6. Global Liquid Biopsy For Cancer Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Liquid Biopsy For Cancer Diagnostics Market Share by Application: 2022 VS 2033
Figure 8. Hospital Case Studies
Figure 9. Diagnostic Center Case Studies
Figure 10. Others Case Studies
Figure 11. Liquid Biopsy For Cancer Diagnostics Report Years Considered
Figure 12. Global Liquid Biopsy For Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Liquid Biopsy For Cancer Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Liquid Biopsy For Cancer Diagnostics Market Share by Region: 2022 VS 2033
Figure 15. Global Liquid Biopsy For Cancer Diagnostics Market Share by Players in 2022
Figure 16. Global Top Liquid Biopsy For Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Biopsy For Cancer Diagnostics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Liquid Biopsy For Cancer Diagnostics Revenue in 2022
Figure 18. North America Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Liquid Biopsy For Cancer Diagnostics Market Share by Country (2018-2033)
Figure 20. United States Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Liquid Biopsy For Cancer Diagnostics Market Share by Country (2018-2033)
Figure 24. Germany Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Share by Region (2018-2033)
Figure 32. China Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Liquid Biopsy For Cancer Diagnostics Market Share by Country (2018-2033)
Figure 40. Mexico Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Share by Country (2018-2033)
Figure 44. Turkey Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. F. Hoffman La Roche Ltd. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 47. Thermo Fisher Scientific Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 48. Agilent Technologies Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 49. Illumina Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 50. The Menarini Group Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 51. Bio-Rad Laboratories Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 52. QIAGEN Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 53. Exact Sciences Corporation Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 54. Bio-Techne Corporation Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 55. ArcherDX Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 56. Neogenomics Laboratories Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 57. Guardant Health Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 58. Myriad Genetics Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 59. Foundation Medicine Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 60. Amoy Diagnostics Co. Ltd. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 61. Biocartis Group NV Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed